Fair Value Calculator Fair Value Calculator
EN DE

IKS (IKS) Fair Value & Analysis

IN · Market cap ₹312B

I IKS IKS · BSE
Price₹1,858
Fair Value₹830.74
Upside-55.3%
Quality68/100
Watch IKS for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹619.30 – ₹2,366

Fair value as of: Jul 5, 2026

From 26 valuation models · updated today

Share price +8.8% over the past month.

Price vs Fair Value (12 months)

₹1,858 ₹1,268 Fair Value ₹830.74 Jul 2025 Jul 2026

12‑month range ₹1,268 – ₹1,858 · fair‑value band ₹619.30 – ₹2,366 · the ₹1,858 price screens above the ₹830.74 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

IKS (IKS) currently trades at ₹1,858, while our model-based Fair Value estimate is ₹830.74 — implying the stock looks roughly 55.3% overvalued today. We read business quality at 68/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, IKS generated revenue of ₹31.9B at a net margin of 22.6%. Revenue grew 18.5% year over year. It earns a return on equity of 31.4%. Net debt stands at ₹2.5B. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹619.30 (bear case) to ₹2,366 (bull case); at ₹1,858, the current price sits within that range. The share trades about 1% below its 52-week high and 47% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹31.9B
Revenue growth (YoY) +18.5%
Net margin 22.6%
Return on equity 31.4%
Free cash flow ₹6.1B FY2026
P/E ratio 44.1
More key figures
Operating margin 35.1%
EPS (TTM) ₹42.18
EPS growth (YoY) +38.6%
Net debt ₹2.5B FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

IKS reported revenue of ₹31.9B in FY2026 versus ₹7.6B in FY2022, a compound +43.0%/yr. Reported net income was ₹7.2B in FY2026, compounding +32.7%/yr from FY2022.

Revenue +43.0%/yr
FY22 ₹7.6B
FY23 ₹10.3B
FY24 ₹18.2B
FY25 ₹26.6B
FY26 ₹31.9B
Net income +32.7%/yr
FY22 ₹2.3B
FY23 ₹3.1B
FY24 ₹3.7B
FY25 ₹4.9B
FY26 ₹7.2B

Is IKS fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "IKS Fair Value". https://www.fairvalue-calculator.com/stock/IKS

Recent news

External third-party headlines (Yahoo Finance, Reuters and others) — not an editorial selection, not financial advice.

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is IKS (IKS) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹830.74 versus a price of ₹1,858 — about −55% (overvalued). Model-based estimate, not financial advice.
What is the fair value of IKS?
Our model-based fair value for IKS is ₹830.74 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹1,858.
What is the quality score of IKS?
IKS has a Quality Score of 68/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of IKS (IKS)?
IKS reported trailing-twelve-month revenue of about ₹31.9B (latest available figure, as of Jul 5, 2026).
What is the net profit margin of IKS?
The net profit margin of IKS is about 22.6%, meaning it keeps roughly 22.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.